Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Status |
|---|---|---|---|
| 1 | ₹3.6 LAdmitted-Finance 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Takeda Biopharmaceuticals India Private Limited |
|---|---|---|---|---|
| 1.00 | VEDOLIZUMAB 300MG INJ | 6 | INJ | 3,46,320 ₹3,63,636 Lowest |
Tender Value
Refer Docs
Closing Date
5 Dec 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
R. RAVI KUMAR
BHEL HYDERABAD
VEDOLIZUMAB 300MG INJ
2025_BHEL_55333_1
HYI2500110
Single
Miscellaneous Goods
Buy
300 days
BHEL HYDERABAD
AS PER NIT
4 documents required · 4 mandatory
₹0
Exempted
12 Dec 2025
27 Nov 2025
6 Dec 2025
27 Nov 2025
5 Dec 2025
27 Nov 2025
stage.html
html • 0.02 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .